Lyra Therapeutics, Inc. (LYRA)
NASDAQ: LYRA · Real-Time Price · USD
1.885
-0.095 (-4.80%)
Feb 4, 2026, 4:00 PM EST - Market closed
Lyra Therapeutics Market Cap
Lyra Therapeutics has a market cap or net worth of $3.35 million as of February 4, 2026. Its market cap has decreased by -73.18% in one year.
Market Cap
3.35M
Enterprise Value
12.72M
1-Year Change
-73.18%
Ranking
Category
Stock Price
$1.89
Market Cap Chart
Since May 1, 2020, Lyra Therapeutics's market cap has decreased from $230.14M to $3.35M, a decrease of -98.55%. That is a compound annual growth rate of -52.00%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 3, 2026 | 3.51M | -35.71% |
| Dec 31, 2025 | 5.47M | -59.54% |
| Dec 31, 2024 | 13.51M | -95.09% |
| Dec 29, 2023 | 275.43M | 175.60% |
| Dec 30, 2022 | 99.94M | 76.26% |
| Dec 31, 2021 | 56.70M | -61.52% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| May 1, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Moolec Science | 3.86M |
| Matinas BioPharma Holdings | 3.86M |
| XORTX Therapeutics | 3.47M |
| Galmed Pharmaceuticals | 3.46M |
| CNS Pharmaceuticals | 3.26M |
| Oragenics | 3.20M |
| Scinai Immunotherapeutics | 3.13M |
| Psyence Biomedical | 3.07M |